FY2024 EPS Estimates for Henry Schein Increased by Analyst

Henry Schein, Inc. (NASDAQ:HSIC) – Equities research analysts at Leerink Partnrs increased their FY2024 EPS estimates for shares of Henry Schein in a research note issued on Tuesday, November 5th. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings per share of $4.81 for the year, up from their prior forecast of $4.76. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein’s Q4 2024 earnings at $1.26 EPS, Q1 2025 earnings at $1.18 EPS, Q2 2025 earnings at $1.26 EPS, Q3 2025 earnings at $1.30 EPS and Q4 2025 earnings at $1.45 EPS.

A number of other equities analysts have also issued reports on HSIC. Barrington Research reiterated an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a research report on Wednesday. Evercore ISI boosted their target price on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. JPMorgan Chase & Co. decreased their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research note on Monday, August 12th. UBS Group dropped their price objective on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. Finally, Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Henry Schein presently has an average rating of “Hold” and an average target price of $77.50.

Henry Schein Trading Down 0.8 %

NASDAQ:HSIC opened at $69.43 on Thursday. The stock has a market cap of $8.80 billion, a price-to-earnings ratio of 25.71, a PEG ratio of 2.08 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.55. Henry Schein has a 1 year low of $62.12 and a 1 year high of $82.63. The business has a fifty day moving average of $70.56 and a 200-day moving average of $69.78.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The company had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. During the same quarter in the previous year, the company posted $1.32 earnings per share. The business’s revenue for the quarter was up .4% compared to the same quarter last year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Henry Schein by 11.8% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 27,894 shares of the company’s stock worth $2,186,000 after purchasing an additional 2,954 shares in the last quarter. Nordea Investment Management AB lifted its stake in Henry Schein by 8.9% in the first quarter. Nordea Investment Management AB now owns 9,785 shares of the company’s stock valued at $744,000 after acquiring an additional 798 shares during the last quarter. Daiwa Securities Group Inc. grew its position in Henry Schein by 11.0% in the first quarter. Daiwa Securities Group Inc. now owns 12,869 shares of the company’s stock worth $972,000 after acquiring an additional 1,279 shares in the last quarter. Empirical Finance LLC increased its stake in shares of Henry Schein by 3.5% during the 1st quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock worth $360,000 after purchasing an additional 160 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. increased its stake in shares of Henry Schein by 64.2% during the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 41,558 shares of the company’s stock worth $3,138,000 after purchasing an additional 16,241 shares during the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Henry Schein

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at $4,978,026.90. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 1.14% of the stock is currently owned by insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.